Therapy and Vein Access Market. Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Therapy and Vein Access ...

Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Therapy and Vein Access Market" report has been added to ResearchAndMarkets.com's offering. The global market for IV therapy and ...

Global Intravenous Equipment Market Poised for Significant Growth amid Rising Healthcare Demands and Technological InnovationsRockville, MD, March 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

Epicrispr has raised $68m in the initial close of its Series B financing round to commence the clinical trial of EPI-321 for ...

CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

One of the most crucial aspects of psychedelic therapy is the process of making meaning from psychedelic experiences and ...

Eli Lilly (LLY) stock in focus as an expert panel of the EU drug regulator declines to endorse its Alzheimer's drug Kisunla.

Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating ...